Germany Makes € 500 Million Pledge To WHO – Plug For ‘Major Funding Gap’ Left By United States 25/06/2020 Svĕt Lustig Vijay & Elaine Ruth Fletcher Germany has pledged an unprecedented € 500 million to the World Health Organization for 2020, making this the “highest amount” ever provided by the country, said Jens Spahn, German Minister of Health at an impromptu WHO press briefing on Thursday. The German contribution, equal to about 20% of WHO’s annual budget, plugs the major funding […] Continue reading -> US $8.8 Billion Pledged For Gavi, The Vaccine Alliance – Smashing US $7.4 Billion Goal 04/06/2020 Grace Ren & Svĕt Lustig Vijay Gavi, the Vaccine Alliance raised a whopping US $8.8 billion at the first ever virtual Global Vaccine Summit co-hosted Thursday by the United Kingdom, surpassing the fundraising goal of US $7.4 billion. “We have secured a fantastic US $8.8. billion for Gavi’s work over the next five years and I’d like to thank everyone very, […] Continue reading -> Ensuring Universal COVID-19 Vaccine Access Requires Political Will & Scaling Production 29/05/2020 Grace Ren As the COVID-19 pandemic continues to ravage the world, hope has been pinned on the development and roll-out of an effective vaccine. But in a global crisis where demand for the vaccine will be everywhere, how can fair and equitable distribution be ensured? Panelists from the World Health Organization; the Coalition for Epidemic Preparedness Innovations […] Continue reading -> Ten Actions To Boost Low & Middle Income Countries’ Productive Capacity For Medicines 25/05/2020 James Zhan & Christoph Spennemann Low and middle-income countries urgently need affordable personal protective equipment, diagnostics, treatments and vaccines to ward off even bigger waves of COVID-19 infection and mortality – and global production capacity is failing to ensure timely supply even of those products now on the market. Now, more than ever, producers in poor countries need to be […] Continue reading -> Pharma Under The Microscope In The COVID-19 Crisis 19/05/2020 Elaine Ruth Fletcher Now, more than ever, the pharma industry has been thrust into the limelight – as the world races to find new drugs and a hoped-for vaccine to beat COVID-19 and ensure universal access to critical treatment. Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), talks about the old-new tensions […] Continue reading -> WHO Member States Agree On Draft Resolution For COVID-19 Response – Overriding US Objections 14/05/2020 Elaine Ruth Fletcher World Health Organization member states reached initial agreement today on a European Union-led draft resolution on global COVID-19 response to go before the upcoming World Health Assembly – overriding some of the previous US objections to language referring to the rights of countries to override patent rules. The draft resolution to be submitted to the […] Continue reading -> Access To Affordable Biologics In The Context Of COVID-19: Will WHO Step Up To Its Responsibility? 14/04/2020 Chetali Rao & K M Gopakumar New Delhi, India – COVID-19 has posed unique challenges for healthcare providers across the globe, as the world has been grappling with the pandemic with no approved treatments or vaccines for the disease. Researchers are searching everywhere for drugs that may help treat or prevent the spread of the deadly virus. This has led to […] Continue reading -> Costa Rica Urges WHO To Lead Global Initiative For Pooled Rights To COVID-19 Diagnostics, Drugs & Vaccines 24/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay Costa Rica’s president, Carlos Alvarado Quesada has appealed to Dr Tedros Adhanom Ghebreyesus, Director General of the World Health Organization, to “pool rights to technologies that are useful for the detection, prevention, control and treatment of the COVID-19 pandemic”. The presidential letter dated Monday, 23 March, and co-signed by Minister of Health, Daniel Salas Peraza, […] Continue reading -> New COVID-19 Diagnostics Offer Hope – But “Broadbased Testing Not Possible” Says Roche Industry Leader 19/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay New high-throughput test technologies that can process thousands of COVID-19 samples a day are coming online. But the CEO of Roche Pharmaceuticals, which recently gained US Food and Drug Administration approval for a new high-volume test, asserted Thursday that “broad-based testing is simply not feasible.” Severin Schwan, Roche CEO, was speaking at a press conference […] Continue reading -> WHO Protests Price Shocks & Hoarding Of Vital Protective Gear Needed To Fight Coronavirus; WHO Executive Board Calls For More Preparedness 07/02/2020 Elaine Ruth Fletcher The world is facing a “severe disruption” in stocks of personal protective equipment vital for health workers to fight the novel coronavirus raging through China’s Hubei Province and threatening other countries worldwide, said WHO Director-General Dr Tedros Adhanom Ghebreyesus at a Friday press briefing. The Director-General spoke as cases of the new (2019-nCoV) virus continued […] Continue reading -> Posts navigation Older postsNewer posts
US $8.8 Billion Pledged For Gavi, The Vaccine Alliance – Smashing US $7.4 Billion Goal 04/06/2020 Grace Ren & Svĕt Lustig Vijay Gavi, the Vaccine Alliance raised a whopping US $8.8 billion at the first ever virtual Global Vaccine Summit co-hosted Thursday by the United Kingdom, surpassing the fundraising goal of US $7.4 billion. “We have secured a fantastic US $8.8. billion for Gavi’s work over the next five years and I’d like to thank everyone very, […] Continue reading -> Ensuring Universal COVID-19 Vaccine Access Requires Political Will & Scaling Production 29/05/2020 Grace Ren As the COVID-19 pandemic continues to ravage the world, hope has been pinned on the development and roll-out of an effective vaccine. But in a global crisis where demand for the vaccine will be everywhere, how can fair and equitable distribution be ensured? Panelists from the World Health Organization; the Coalition for Epidemic Preparedness Innovations […] Continue reading -> Ten Actions To Boost Low & Middle Income Countries’ Productive Capacity For Medicines 25/05/2020 James Zhan & Christoph Spennemann Low and middle-income countries urgently need affordable personal protective equipment, diagnostics, treatments and vaccines to ward off even bigger waves of COVID-19 infection and mortality – and global production capacity is failing to ensure timely supply even of those products now on the market. Now, more than ever, producers in poor countries need to be […] Continue reading -> Pharma Under The Microscope In The COVID-19 Crisis 19/05/2020 Elaine Ruth Fletcher Now, more than ever, the pharma industry has been thrust into the limelight – as the world races to find new drugs and a hoped-for vaccine to beat COVID-19 and ensure universal access to critical treatment. Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), talks about the old-new tensions […] Continue reading -> WHO Member States Agree On Draft Resolution For COVID-19 Response – Overriding US Objections 14/05/2020 Elaine Ruth Fletcher World Health Organization member states reached initial agreement today on a European Union-led draft resolution on global COVID-19 response to go before the upcoming World Health Assembly – overriding some of the previous US objections to language referring to the rights of countries to override patent rules. The draft resolution to be submitted to the […] Continue reading -> Access To Affordable Biologics In The Context Of COVID-19: Will WHO Step Up To Its Responsibility? 14/04/2020 Chetali Rao & K M Gopakumar New Delhi, India – COVID-19 has posed unique challenges for healthcare providers across the globe, as the world has been grappling with the pandemic with no approved treatments or vaccines for the disease. Researchers are searching everywhere for drugs that may help treat or prevent the spread of the deadly virus. This has led to […] Continue reading -> Costa Rica Urges WHO To Lead Global Initiative For Pooled Rights To COVID-19 Diagnostics, Drugs & Vaccines 24/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay Costa Rica’s president, Carlos Alvarado Quesada has appealed to Dr Tedros Adhanom Ghebreyesus, Director General of the World Health Organization, to “pool rights to technologies that are useful for the detection, prevention, control and treatment of the COVID-19 pandemic”. The presidential letter dated Monday, 23 March, and co-signed by Minister of Health, Daniel Salas Peraza, […] Continue reading -> New COVID-19 Diagnostics Offer Hope – But “Broadbased Testing Not Possible” Says Roche Industry Leader 19/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay New high-throughput test technologies that can process thousands of COVID-19 samples a day are coming online. But the CEO of Roche Pharmaceuticals, which recently gained US Food and Drug Administration approval for a new high-volume test, asserted Thursday that “broad-based testing is simply not feasible.” Severin Schwan, Roche CEO, was speaking at a press conference […] Continue reading -> WHO Protests Price Shocks & Hoarding Of Vital Protective Gear Needed To Fight Coronavirus; WHO Executive Board Calls For More Preparedness 07/02/2020 Elaine Ruth Fletcher The world is facing a “severe disruption” in stocks of personal protective equipment vital for health workers to fight the novel coronavirus raging through China’s Hubei Province and threatening other countries worldwide, said WHO Director-General Dr Tedros Adhanom Ghebreyesus at a Friday press briefing. The Director-General spoke as cases of the new (2019-nCoV) virus continued […] Continue reading -> Posts navigation Older postsNewer posts
Ensuring Universal COVID-19 Vaccine Access Requires Political Will & Scaling Production 29/05/2020 Grace Ren As the COVID-19 pandemic continues to ravage the world, hope has been pinned on the development and roll-out of an effective vaccine. But in a global crisis where demand for the vaccine will be everywhere, how can fair and equitable distribution be ensured? Panelists from the World Health Organization; the Coalition for Epidemic Preparedness Innovations […] Continue reading -> Ten Actions To Boost Low & Middle Income Countries’ Productive Capacity For Medicines 25/05/2020 James Zhan & Christoph Spennemann Low and middle-income countries urgently need affordable personal protective equipment, diagnostics, treatments and vaccines to ward off even bigger waves of COVID-19 infection and mortality – and global production capacity is failing to ensure timely supply even of those products now on the market. Now, more than ever, producers in poor countries need to be […] Continue reading -> Pharma Under The Microscope In The COVID-19 Crisis 19/05/2020 Elaine Ruth Fletcher Now, more than ever, the pharma industry has been thrust into the limelight – as the world races to find new drugs and a hoped-for vaccine to beat COVID-19 and ensure universal access to critical treatment. Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), talks about the old-new tensions […] Continue reading -> WHO Member States Agree On Draft Resolution For COVID-19 Response – Overriding US Objections 14/05/2020 Elaine Ruth Fletcher World Health Organization member states reached initial agreement today on a European Union-led draft resolution on global COVID-19 response to go before the upcoming World Health Assembly – overriding some of the previous US objections to language referring to the rights of countries to override patent rules. The draft resolution to be submitted to the […] Continue reading -> Access To Affordable Biologics In The Context Of COVID-19: Will WHO Step Up To Its Responsibility? 14/04/2020 Chetali Rao & K M Gopakumar New Delhi, India – COVID-19 has posed unique challenges for healthcare providers across the globe, as the world has been grappling with the pandemic with no approved treatments or vaccines for the disease. Researchers are searching everywhere for drugs that may help treat or prevent the spread of the deadly virus. This has led to […] Continue reading -> Costa Rica Urges WHO To Lead Global Initiative For Pooled Rights To COVID-19 Diagnostics, Drugs & Vaccines 24/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay Costa Rica’s president, Carlos Alvarado Quesada has appealed to Dr Tedros Adhanom Ghebreyesus, Director General of the World Health Organization, to “pool rights to technologies that are useful for the detection, prevention, control and treatment of the COVID-19 pandemic”. The presidential letter dated Monday, 23 March, and co-signed by Minister of Health, Daniel Salas Peraza, […] Continue reading -> New COVID-19 Diagnostics Offer Hope – But “Broadbased Testing Not Possible” Says Roche Industry Leader 19/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay New high-throughput test technologies that can process thousands of COVID-19 samples a day are coming online. But the CEO of Roche Pharmaceuticals, which recently gained US Food and Drug Administration approval for a new high-volume test, asserted Thursday that “broad-based testing is simply not feasible.” Severin Schwan, Roche CEO, was speaking at a press conference […] Continue reading -> WHO Protests Price Shocks & Hoarding Of Vital Protective Gear Needed To Fight Coronavirus; WHO Executive Board Calls For More Preparedness 07/02/2020 Elaine Ruth Fletcher The world is facing a “severe disruption” in stocks of personal protective equipment vital for health workers to fight the novel coronavirus raging through China’s Hubei Province and threatening other countries worldwide, said WHO Director-General Dr Tedros Adhanom Ghebreyesus at a Friday press briefing. The Director-General spoke as cases of the new (2019-nCoV) virus continued […] Continue reading -> Posts navigation Older postsNewer posts
Ten Actions To Boost Low & Middle Income Countries’ Productive Capacity For Medicines 25/05/2020 James Zhan & Christoph Spennemann Low and middle-income countries urgently need affordable personal protective equipment, diagnostics, treatments and vaccines to ward off even bigger waves of COVID-19 infection and mortality – and global production capacity is failing to ensure timely supply even of those products now on the market. Now, more than ever, producers in poor countries need to be […] Continue reading -> Pharma Under The Microscope In The COVID-19 Crisis 19/05/2020 Elaine Ruth Fletcher Now, more than ever, the pharma industry has been thrust into the limelight – as the world races to find new drugs and a hoped-for vaccine to beat COVID-19 and ensure universal access to critical treatment. Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), talks about the old-new tensions […] Continue reading -> WHO Member States Agree On Draft Resolution For COVID-19 Response – Overriding US Objections 14/05/2020 Elaine Ruth Fletcher World Health Organization member states reached initial agreement today on a European Union-led draft resolution on global COVID-19 response to go before the upcoming World Health Assembly – overriding some of the previous US objections to language referring to the rights of countries to override patent rules. The draft resolution to be submitted to the […] Continue reading -> Access To Affordable Biologics In The Context Of COVID-19: Will WHO Step Up To Its Responsibility? 14/04/2020 Chetali Rao & K M Gopakumar New Delhi, India – COVID-19 has posed unique challenges for healthcare providers across the globe, as the world has been grappling with the pandemic with no approved treatments or vaccines for the disease. Researchers are searching everywhere for drugs that may help treat or prevent the spread of the deadly virus. This has led to […] Continue reading -> Costa Rica Urges WHO To Lead Global Initiative For Pooled Rights To COVID-19 Diagnostics, Drugs & Vaccines 24/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay Costa Rica’s president, Carlos Alvarado Quesada has appealed to Dr Tedros Adhanom Ghebreyesus, Director General of the World Health Organization, to “pool rights to technologies that are useful for the detection, prevention, control and treatment of the COVID-19 pandemic”. The presidential letter dated Monday, 23 March, and co-signed by Minister of Health, Daniel Salas Peraza, […] Continue reading -> New COVID-19 Diagnostics Offer Hope – But “Broadbased Testing Not Possible” Says Roche Industry Leader 19/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay New high-throughput test technologies that can process thousands of COVID-19 samples a day are coming online. But the CEO of Roche Pharmaceuticals, which recently gained US Food and Drug Administration approval for a new high-volume test, asserted Thursday that “broad-based testing is simply not feasible.” Severin Schwan, Roche CEO, was speaking at a press conference […] Continue reading -> WHO Protests Price Shocks & Hoarding Of Vital Protective Gear Needed To Fight Coronavirus; WHO Executive Board Calls For More Preparedness 07/02/2020 Elaine Ruth Fletcher The world is facing a “severe disruption” in stocks of personal protective equipment vital for health workers to fight the novel coronavirus raging through China’s Hubei Province and threatening other countries worldwide, said WHO Director-General Dr Tedros Adhanom Ghebreyesus at a Friday press briefing. The Director-General spoke as cases of the new (2019-nCoV) virus continued […] Continue reading -> Posts navigation Older postsNewer posts
Pharma Under The Microscope In The COVID-19 Crisis 19/05/2020 Elaine Ruth Fletcher Now, more than ever, the pharma industry has been thrust into the limelight – as the world races to find new drugs and a hoped-for vaccine to beat COVID-19 and ensure universal access to critical treatment. Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), talks about the old-new tensions […] Continue reading -> WHO Member States Agree On Draft Resolution For COVID-19 Response – Overriding US Objections 14/05/2020 Elaine Ruth Fletcher World Health Organization member states reached initial agreement today on a European Union-led draft resolution on global COVID-19 response to go before the upcoming World Health Assembly – overriding some of the previous US objections to language referring to the rights of countries to override patent rules. The draft resolution to be submitted to the […] Continue reading -> Access To Affordable Biologics In The Context Of COVID-19: Will WHO Step Up To Its Responsibility? 14/04/2020 Chetali Rao & K M Gopakumar New Delhi, India – COVID-19 has posed unique challenges for healthcare providers across the globe, as the world has been grappling with the pandemic with no approved treatments or vaccines for the disease. Researchers are searching everywhere for drugs that may help treat or prevent the spread of the deadly virus. This has led to […] Continue reading -> Costa Rica Urges WHO To Lead Global Initiative For Pooled Rights To COVID-19 Diagnostics, Drugs & Vaccines 24/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay Costa Rica’s president, Carlos Alvarado Quesada has appealed to Dr Tedros Adhanom Ghebreyesus, Director General of the World Health Organization, to “pool rights to technologies that are useful for the detection, prevention, control and treatment of the COVID-19 pandemic”. The presidential letter dated Monday, 23 March, and co-signed by Minister of Health, Daniel Salas Peraza, […] Continue reading -> New COVID-19 Diagnostics Offer Hope – But “Broadbased Testing Not Possible” Says Roche Industry Leader 19/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay New high-throughput test technologies that can process thousands of COVID-19 samples a day are coming online. But the CEO of Roche Pharmaceuticals, which recently gained US Food and Drug Administration approval for a new high-volume test, asserted Thursday that “broad-based testing is simply not feasible.” Severin Schwan, Roche CEO, was speaking at a press conference […] Continue reading -> WHO Protests Price Shocks & Hoarding Of Vital Protective Gear Needed To Fight Coronavirus; WHO Executive Board Calls For More Preparedness 07/02/2020 Elaine Ruth Fletcher The world is facing a “severe disruption” in stocks of personal protective equipment vital for health workers to fight the novel coronavirus raging through China’s Hubei Province and threatening other countries worldwide, said WHO Director-General Dr Tedros Adhanom Ghebreyesus at a Friday press briefing. The Director-General spoke as cases of the new (2019-nCoV) virus continued […] Continue reading -> Posts navigation Older postsNewer posts
WHO Member States Agree On Draft Resolution For COVID-19 Response – Overriding US Objections 14/05/2020 Elaine Ruth Fletcher World Health Organization member states reached initial agreement today on a European Union-led draft resolution on global COVID-19 response to go before the upcoming World Health Assembly – overriding some of the previous US objections to language referring to the rights of countries to override patent rules. The draft resolution to be submitted to the […] Continue reading -> Access To Affordable Biologics In The Context Of COVID-19: Will WHO Step Up To Its Responsibility? 14/04/2020 Chetali Rao & K M Gopakumar New Delhi, India – COVID-19 has posed unique challenges for healthcare providers across the globe, as the world has been grappling with the pandemic with no approved treatments or vaccines for the disease. Researchers are searching everywhere for drugs that may help treat or prevent the spread of the deadly virus. This has led to […] Continue reading -> Costa Rica Urges WHO To Lead Global Initiative For Pooled Rights To COVID-19 Diagnostics, Drugs & Vaccines 24/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay Costa Rica’s president, Carlos Alvarado Quesada has appealed to Dr Tedros Adhanom Ghebreyesus, Director General of the World Health Organization, to “pool rights to technologies that are useful for the detection, prevention, control and treatment of the COVID-19 pandemic”. The presidential letter dated Monday, 23 March, and co-signed by Minister of Health, Daniel Salas Peraza, […] Continue reading -> New COVID-19 Diagnostics Offer Hope – But “Broadbased Testing Not Possible” Says Roche Industry Leader 19/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay New high-throughput test technologies that can process thousands of COVID-19 samples a day are coming online. But the CEO of Roche Pharmaceuticals, which recently gained US Food and Drug Administration approval for a new high-volume test, asserted Thursday that “broad-based testing is simply not feasible.” Severin Schwan, Roche CEO, was speaking at a press conference […] Continue reading -> WHO Protests Price Shocks & Hoarding Of Vital Protective Gear Needed To Fight Coronavirus; WHO Executive Board Calls For More Preparedness 07/02/2020 Elaine Ruth Fletcher The world is facing a “severe disruption” in stocks of personal protective equipment vital for health workers to fight the novel coronavirus raging through China’s Hubei Province and threatening other countries worldwide, said WHO Director-General Dr Tedros Adhanom Ghebreyesus at a Friday press briefing. The Director-General spoke as cases of the new (2019-nCoV) virus continued […] Continue reading -> Posts navigation Older postsNewer posts
Access To Affordable Biologics In The Context Of COVID-19: Will WHO Step Up To Its Responsibility? 14/04/2020 Chetali Rao & K M Gopakumar New Delhi, India – COVID-19 has posed unique challenges for healthcare providers across the globe, as the world has been grappling with the pandemic with no approved treatments or vaccines for the disease. Researchers are searching everywhere for drugs that may help treat or prevent the spread of the deadly virus. This has led to […] Continue reading -> Costa Rica Urges WHO To Lead Global Initiative For Pooled Rights To COVID-19 Diagnostics, Drugs & Vaccines 24/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay Costa Rica’s president, Carlos Alvarado Quesada has appealed to Dr Tedros Adhanom Ghebreyesus, Director General of the World Health Organization, to “pool rights to technologies that are useful for the detection, prevention, control and treatment of the COVID-19 pandemic”. The presidential letter dated Monday, 23 March, and co-signed by Minister of Health, Daniel Salas Peraza, […] Continue reading -> New COVID-19 Diagnostics Offer Hope – But “Broadbased Testing Not Possible” Says Roche Industry Leader 19/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay New high-throughput test technologies that can process thousands of COVID-19 samples a day are coming online. But the CEO of Roche Pharmaceuticals, which recently gained US Food and Drug Administration approval for a new high-volume test, asserted Thursday that “broad-based testing is simply not feasible.” Severin Schwan, Roche CEO, was speaking at a press conference […] Continue reading -> WHO Protests Price Shocks & Hoarding Of Vital Protective Gear Needed To Fight Coronavirus; WHO Executive Board Calls For More Preparedness 07/02/2020 Elaine Ruth Fletcher The world is facing a “severe disruption” in stocks of personal protective equipment vital for health workers to fight the novel coronavirus raging through China’s Hubei Province and threatening other countries worldwide, said WHO Director-General Dr Tedros Adhanom Ghebreyesus at a Friday press briefing. The Director-General spoke as cases of the new (2019-nCoV) virus continued […] Continue reading -> Posts navigation Older postsNewer posts
Costa Rica Urges WHO To Lead Global Initiative For Pooled Rights To COVID-19 Diagnostics, Drugs & Vaccines 24/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay Costa Rica’s president, Carlos Alvarado Quesada has appealed to Dr Tedros Adhanom Ghebreyesus, Director General of the World Health Organization, to “pool rights to technologies that are useful for the detection, prevention, control and treatment of the COVID-19 pandemic”. The presidential letter dated Monday, 23 March, and co-signed by Minister of Health, Daniel Salas Peraza, […] Continue reading -> New COVID-19 Diagnostics Offer Hope – But “Broadbased Testing Not Possible” Says Roche Industry Leader 19/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay New high-throughput test technologies that can process thousands of COVID-19 samples a day are coming online. But the CEO of Roche Pharmaceuticals, which recently gained US Food and Drug Administration approval for a new high-volume test, asserted Thursday that “broad-based testing is simply not feasible.” Severin Schwan, Roche CEO, was speaking at a press conference […] Continue reading -> WHO Protests Price Shocks & Hoarding Of Vital Protective Gear Needed To Fight Coronavirus; WHO Executive Board Calls For More Preparedness 07/02/2020 Elaine Ruth Fletcher The world is facing a “severe disruption” in stocks of personal protective equipment vital for health workers to fight the novel coronavirus raging through China’s Hubei Province and threatening other countries worldwide, said WHO Director-General Dr Tedros Adhanom Ghebreyesus at a Friday press briefing. The Director-General spoke as cases of the new (2019-nCoV) virus continued […] Continue reading -> Posts navigation Older postsNewer posts
New COVID-19 Diagnostics Offer Hope – But “Broadbased Testing Not Possible” Says Roche Industry Leader 19/03/2020 Elaine Ruth Fletcher & Svĕt Lustig Vijay New high-throughput test technologies that can process thousands of COVID-19 samples a day are coming online. But the CEO of Roche Pharmaceuticals, which recently gained US Food and Drug Administration approval for a new high-volume test, asserted Thursday that “broad-based testing is simply not feasible.” Severin Schwan, Roche CEO, was speaking at a press conference […] Continue reading -> WHO Protests Price Shocks & Hoarding Of Vital Protective Gear Needed To Fight Coronavirus; WHO Executive Board Calls For More Preparedness 07/02/2020 Elaine Ruth Fletcher The world is facing a “severe disruption” in stocks of personal protective equipment vital for health workers to fight the novel coronavirus raging through China’s Hubei Province and threatening other countries worldwide, said WHO Director-General Dr Tedros Adhanom Ghebreyesus at a Friday press briefing. The Director-General spoke as cases of the new (2019-nCoV) virus continued […] Continue reading -> Posts navigation Older postsNewer posts
WHO Protests Price Shocks & Hoarding Of Vital Protective Gear Needed To Fight Coronavirus; WHO Executive Board Calls For More Preparedness 07/02/2020 Elaine Ruth Fletcher The world is facing a “severe disruption” in stocks of personal protective equipment vital for health workers to fight the novel coronavirus raging through China’s Hubei Province and threatening other countries worldwide, said WHO Director-General Dr Tedros Adhanom Ghebreyesus at a Friday press briefing. The Director-General spoke as cases of the new (2019-nCoV) virus continued […] Continue reading -> Posts navigation Older postsNewer posts